NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
iRhythm Holdings, Inc. IRTC
12 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$747.1M
▲ 26.2% vs FY2024
EPS · FY25
$-1.39
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-36.6%
Net margin · FY25
-6.0%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 747.1M
Revenue, FY2025 · full 12-year series below
Revenue
Net income
The company lost 6 cents on every revenue dollar this year.
Per share
USD -1.39
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-36.6%
Return on equity, FY2025
ROE
Operating margin-7.7%
Net margin-6.0%
Return on assets-4.6%
Each USD of equity lost 37 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 0.00
Share of profit-0.0%
Consecutive raises—
Growth
+23.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+22.1%
+23.0%
+35.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.03B
Shares outstanding, FY2025
Change, 5 years+11.3%
Change, 10 years—
The share count grew 11% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.0B
total assets, end of FY2025
Total assetsUSD 1.0B
EquityUSD 152.7M
CashUSD 236.0M
Current ratio4.63×
Equity funds 15% of total assets.
History
12 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue $B
0.7
0.6
0.5
0.4
0.3
0.3
0.2
0.1
0.1
0.1
0.0
0.0
Operating income $B
−0.1
−0.1
−0.1
−0.1
−0.1
−0.0
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.1
−0.1
−0.1
−0.1
−0.0
·
·
·
·
·
·
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
−0.0
−0.1
−0.1
−0.1
−0.1
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.39
−3.63
−4.04
−3.88
−3.46
−1.58
−2.16
−2.11
−1.31
−3.95
−16.57
−12.05
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−36.6
−75.3
−54.9
−44.7
−32.6
−18.4
−58.2
−76.6
−34.5
·
·
·
Shares out B
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
46 of 46
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed